D-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma

Journal of Lipid Research

Volumn 52, Issue 3, 2011, Pages 499-508

  Nandedkar, S D ^a   Weihrauch, D ^a   Xu, H ^a   Shi, Y ^a   Feroah, T ^a   Hutchins, W ^a   Rickaby, D A ^a   Duzgunes, N ^b   Hillery, C A ^a   Konduri, K S ^a   Pritchard Jr , K A ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Airway resistance; Apolipoprotein; Proinflammatory lipids

Indexed keywords

4 HYDROXYNONENAL; ACETYLASPARTYLTRYPTOPHYLPHENYLALANYLALANYLLYSYLASPARTYLTYROSYLPHENYLALANYLLYSYLLYSYLALANYLPHENYLALANYLVALYLGLUTAMYLGLUTAMYLPHENYLALANYLALANYLLYSYLAMIDE; APOLIPOPROTEIN A1; AUTOANTIBODY; CALVASCULIN; COLLAGEN; EOSINOPHIL PEROXIDASE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN E; LIPID; PEPTIDE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

AIRWAY RESISTANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASTHMA; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVITY; EOSINOPHIL; EOSINOPHIL COUNT; INFLAMMATION; LIPID OXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRACHEOBRONCHIAL TOILET;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEIN A-I; ASTHMA; BIOMIMETIC MATERIALS; CELL COUNT; CHOLESTEROL, HDL; COLLAGEN; DISEASE MODELS, ANIMAL; EOSINOPHIL PEROXIDASE; EOSINOPHILS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; LUNG; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; PEPTIDES; PNEUMONIA; RESPIRATORY SYSTEM;

EID: 79953206963     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M012724     Document Type: Article

References (58)

1. Update 2002:Expert Panel Report. NAEPP Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002. National Asthma Education and Prevention Program. (Accessed December 10, 2010, at http://www.nhlbi.nih.gov/guidelines/asthma/index.htm.)
2. Weiss, K. B., and S. D. Sullivan. 2001. The health economics of asthma and rhinitis. I. Assessing the economic impact. J. Allergy Clin. Immunol. 107:3-8.
3. Taube, C., N. Miyahara, V. Ott, B. Swanson, K. Takeda, J. Loader, L. D. Shultz, A. M. Tager, A. D. Luster, A. Dakhama, et al. 2006. The leukotriene B4 receptor (BLT1) is required for effector CD8+ T cell-mediated, mast cell-dependent airway hyperresponsiveness. J. Immunol. 176:3157-3164.
4. Bates, S. R., J. Q. Tao, H. L. Collins, O. L. Francone, and G. H. Rothblat. 2005. Pulmonary abnormalities due to ABCA1 deficiency in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 289:L980-L989.
5. Otera, H., T. Ishida, T. Nishiuma, K. Kobayashi, Y. Kotani, T. Yasuda, R. K. Kundu, T. Quertermous, K. Hirata, and Y. Nishimura. 2009. Targeted inactivation of endothelial lipase attenuates lung allergic inflammation through raising plasma HDL level and inhibiting eosinophil infiltration. Am. J. Physiol. Lung Cell. Mol. Physiol. 296:L594-L602.
6. Wang, W., H. Xu, Y. Shi, S. Nandedkar, H. Zhang, H. Gao, T. Feroah, D. Weihrauch, M. L. Schulte, D. W. Jones, et al. 2010. Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung. J. Lipid Res. 51:2560-2570.
7. Bowler, R. P., and J. D. Crapo. 2002. Oxidative stress in allergic respiratory diseases. J. Allergy Clin. Immunol. 110:349-356.
8. Riedl, M. A., and A. E. Nel. 2008. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr. Opin. Allergy Clin. Immunol. 8:49-56.
9. Sedgwick, J. B., Y. S. Hwang, H. A. Gerbyshak, H. Kita, and W. W. Busse. 2003. Oxidized low-density lipoprotein activates migration and degranulation of human granulocytes. Am. J. Respir. Cell Mol. Biol. 29:702-709.
10. Ekmekci, O. B., O. Donma, H. Ekmekci, N. Yildirim, O. Uysal, E. Sardogan, H. Demirel, and T. Demir. 2006. Plasma paraoxonase activities, lipoprotein oxidation, and trace element interaction in asthmatic patients. Biol. Trace Elem. Res. 111:41-52.
11. Fitzpatrick, A. M., W. G. Teague, F. Holguin, M. Yeh, and L. A. Brown. 2009. Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. J. Allergy Clin. Immunol. 123:146-152 e8.
12. Van Lenten, B. J., S. Y. Hama, F. C. de Beer, D. M. Stafforini, T. M. McIntyre, S. M. Prescott, B. N. La Du, A. M. Fogelman, and M. Navab. 1995. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J. Clin. Invest. 96:2758-2767.
13. Van Lenten, B. J., A. C. Wagner, D. P. Nayak, S. Hama, M. Navab, and A. M. Fogelman. 2001. High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection. Circulation. 103:2283-2288.
14. Navab, M., G. M. Anantharamaiah, S. T. Reddy, B. J. Van Lenten, G. Hough, A. Wagner, K. Nakamura, D. W. Garber, G. Datta, J. P. Segrest, et al. 2003. Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis. Curr. Opin. Investig. Drugs. 4:1100-1104.
15. Van Lenten, B. J., A. C. Wagner, M. Navab, G. M. Anantharamaiah, E. K. Hui, D. P. Nayak, and A. M. Fogelman. 2004. D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation. 110:3252-3258.
16. Ou, J., Z. Ou, D. W. Jones, S. Holzhauer, O. A. Hatoum, A. W. Ackerman, D. W. Weihrauch, D. D. Gutterman, K. Guice, K. T. Oldham, et al. 2003. L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease. Circulation. 107:2337-2341. (Pubitemid 36578505)
17. Weihrauch, D., H. Xu, Y. Shi, J. Wang, J. Brien, D. W. Jones, S. Kaul, R. A. Komorowski, M. E. Csuka, K. T. Oldham, et al. 2007. Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation and angiogenic potential in tight-skin mice. Am. J. Physiol. Heart Circ. Physiol. 293:H1432-H1441.
18. Nandedkar, S. D., T. R. Feroah, W. Hutchins, D. Weihrauch, K. S. Konduri, J. Wang, R. C. Strunk, M. R. DeBaun, C. A. Hillery, and K. A. Pritchard. 2008. Histopathology of experimentally induced asthma in a murine model of sickle cell disease. Blood. 112:2529-2538.
19. Ou, J., J. Wang, H. Xu, Z. Ou, M. G. Sorci-Thomas, D. W. Jones, P. Signorino, J. C. Densmore, S. Kaul, K. T. Oldham, et al. 2005. Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet. Circ. Res. 97:1190-1197.
20. Navab, M., G. M. Anantharamaiah, S. Hama, D. W. Garber, M. Chaddha, G. Hough, R. Lallone, and A. M. Fogelman. 2002. Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation. 105:290-292.
21. Nandedkar, S. D., T. R. Feroah, W. Hutchins, D. Weihrauch, K. S. Konduri, J. Wang, R. C. Strunk, M. R. DeBaun, C. A. Hillery, and K. A. Pritchard Jr. 2008. Histopathology of experimentally-induced asthma in a murine model of sickle cell disease. Blood. 112: 2529-2538.
22. Gomes, R. F., and J. H. Bates. 2002. Geometric determinants of airway resistance in two isomorphic rodent species. Respir. Physiol. Neurobiol. 130:317-325.
23. Hirai, T., and J. H. Bates. 2001. Effects of deep inspiration on bronchoconstriction in the rat. Respir. Physiol. 127:201-215.
24. Hirai, T., K. A. McKeown, R. F. Gomes, and J. H. Bates. 1999. Effects of lung volume on lung and chest wall mechanics in rats. J. Appl. Physiol. 86:16-21.
25. Schuessler, T. F., S. B. Gottfried, and J. H. Bates. 1997. A model of the spontaneously breathing patient: applications to intrinsic PEEP and work of breathing. J. Appl. Physiol. 82:1694-1703.
26. Tomioka, S., J. H. Bates, and C. G. Irvin. 2002. Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations. J. Appl. Physiol. 93:263-270.
27. Finotto, S., M. F. Neurath, J. N. Glickman, S. Qin, H. A. Lehr, F. H. Green, K. Ackerman, K. Haley, P. R. Galle, S. J. Szabo, et al. 2002. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science. 295:336-338. (Pubitemid 34074365)
28. Schuessler, T. F., and J. H. Bates. 1995. A computer-controlled research ventilator for small animals: design and evaluation. IEEE Trans. Biomed. Eng. 42:860-866.
29. Gomes, R. F., X. Shen, R. Ramchandani, R. S. Tepper, and J. H. Bates. 2000. Comparative respiratory system mechanics in rodents. J. Appl. Physiol. 89:908-916.
30. Shaw, P. X., S. Horkko, M. K. Chang, L. K. Curtiss, W. Palinski, G. J. Silverman, and J. L. Witztum. 2000. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105:1731-1740.
31. Bole, D. G., L. M. Hendershot, and J. F. Kearney. 1986. Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas. J. Cell Biol. 102:1558-1566.
32. Kearney, J. F., R. Barletta, Z. S. Quan, and J. Quintans. 1981. Monoclonal vs. heterogeneous anti-H-8 antibodies in the analysis of the anti-phosphorylcholine response in BALB/c mice. Eur. J. Immunol. 11:877-883.
33. Stepp, D. W., J. Ou, A. W. Ackerman, S. Welak, D. Klick, and K. A. Pritchard, Jr. 2002. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am. J. Physiol. Heart Circ. Physiol. 283:H750-H759.
34. Navab, M., S. Y. Hama, G. P. Hough, G. Subbanagounder, S. T. Reddy, and A. M. Fogelman. 2001. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J. Lipid Res. 42:1308-1317.
35. Datta, G., R. F. Epand, R. M. Epand, M. Chaddha, M. A. Kirksey, D. W. Garber, S. Lund-Katz, M. C. Phillips, S. Hama, M. Navab, et al. 2004. Aromatic residue position on the nonpolar face of class A amphipathic helical peptides determines biological activity. J. Biol. Chem. 279:26509-26527.
36. Williams, T. J. 2004. The eosinophil enigma. J. Clin. Invest. 113:507-509.
37. Arciniegas, E., M. G. Frid, I. S. Douglas, and K. R. Stenmark. 2007. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 293:L1-L8.
38. Binder, C. J., K. Hartvigsen, M. K. Chang, M. Miller, D. Broide, W. Palinski, L. K. Curtiss, M. Corr, and J. L. Witztum. 2004. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J. Clin. Invest. 114:427-437.
39. Willis, B. C., J. M. Liebler, K. Luby-Phelps, A. G. Nicholson, E. D. Crandall, R. M. du Bois, and Z. Borok. 2005. Induction of epithelialmesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 166:1321-1332.
40. O'Riordan, E., N. Mendelev, S. Patschan, D. Patschan, J. Eskander, L. Cohen-Gould, P. Chander, and M. S. Goligorsky. 2007. Chronic NOS inhibition actuates endothelial-mesenchymal transformation. Am. J. Physiol. Heart Circ. Physiol. 292:H285-H294.
41. Kobayashi, M., H. Sugiyama, D. H. Wang, N. Toda, Y. Maeshima, Y. Yamasaki, N. Masuoka, M. Yamada, S. Kira, and H. Makino. 2005. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int. 68:1018-1031. (Pubitemid 43246418)
42. Uchida, K., L. I. Szweda, H. Z. Chae, and E. R. Stadtman. 1993. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc. Natl. Acad. Sci. USA. 90:8742-8746.
43. Strohmaier, H., H. Hinghofer-Szalkay, and R. J. Schaur. 1995. Detection of 4-hydroxynonenal (HNE) as a physiological component in human plasma. J. Lipid Mediat. Cell Signal. 11:51-61.
44. Sunyer, J., J. M. Anto, J. Castellsague, J. B. Soriano, and J. Roca. 1996. Total serum IgE is associated with asthma independently of specific IgE levels. The Spanish Group of the European Study of Asthma. Eur. Respir. J. 9:1880-1884.
45. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
46. Van Lenten, B. J., A. C. Wagner, C. L. Jung, P. Ruchala, A. J. Waring, R. I. Lehrer, A. D. Watson, S. Hama, M. Navab, G. M. Anantharamaiah, et al. 2008. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J. Lipid Res. 49:2302-2311.
47. Navab, M., G. M. Anantharamaiah, S. T. Reddy, S. Hama, G. Hough, V. R. Grijalva, N. Yu, B. J. Ansell, G. Datta, D. W. Garber, et al. 2005. Apolipoprotein A-I mimetic peptides. Arterioscler. Thromb. Vasc. Biol. 25:1325-1331.
48. Tall, A. R., X. Jiang, Y. Luo, and D. Silver. 2000. 1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 20:1185-1188.
49. Kruger, A. L., S. Peterson, S. Turkseven, P. M. Kaminski, F. F. Zhang, S. Quan, M. S. Wolin, and N. G. Abraham. 2005. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation. 111:3126-3134.
50. Gharavi, N. M., P. S. Gargalovic, I. Chang, J. A. Araujo, M. J. Clark, W. L. Szeto, A. D. Watson, A. J. Lusis, and J. A. Berliner. 2007. High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory. Arterioscler. Thromb. Vasc. Biol. 27:1346-1353.
51. Tang, C., A. M. Vaughan, G. M. Anantharamaiah, and J. F. Oram. 2006. Janus kinase 2 modulates the lipid-removing but not protein-stabilizing interactions of amphipathic helices with ABCA1. J. Lipid Res. 47:107-114.
52. Reddy, S. T., S. Hama, C. Ng, V. Grijalva, M. Navab, and A. M. Fogelman. 2002. ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells. Arterioscler. Thromb. Vasc. Biol. 22:1877-1883.
53. Tang, C., Y. Liu, P. S. Kessler, A. M. Vaughan, and J. F. Oram. 2009. The macrophage cholesterol exporter ABCA1 functions as an antiinfl ammatory receptor. J. Biol. Chem. 284:32336-32343.
54. Ten Broeke, R., R. De Crom, R. Van Haperen, V. Verweij, T. Leusink-Muis, I. Van Ark, F. De Clerck, F. P. Nijkamp, and G. Folkerts. 2006. Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice. Respir. Res. 7:58.
55. Ou, Z., J. Ou, A. W. Ackerman, K. T. Oldham, and K. A. Pritchard, Jr. 2003. L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells. Circulation. 107:1520-1524.
56. Pritchard, K. A., Jr., A. W. Ackerman, E. R. Gross, D. W. Stepp, Y. Shi, J. T. Fontana, J. E. Baker, and W. C. Sessa. 2001. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J. Biol. Chem. 276:17621-17624.
57. Pritchard, K. A., A. W. Ackerman, J. Ou, M. Curtis, D. M. Smalley, J. T. Fontana, M. B. Stemerman, and W. C. Sessa. 2002. Native lowdensity lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1. Free Radic. Biol. Med. 33:52-62.
58. Ou, J., Z. Ou, A. W. Ackerman, K. T. Oldham, and K. A. Pritchard, Jr. 2003. Inhibition of heat shock protein 90 (hsp90) in proliferating endothelial cells uncouples endothelial nitric oxide synthase activity. Free Radic. Biol. Med. 34:269-276.